These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11225605)

  • 1. P-selectin and glycoprotein 53 expression in myeloproliferative disorders.
    Cahill MR
    Br J Haematol; 2001 Jan; 112(1):253. PubMed ID: 11225605
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls.
    Cahill MR; Macey MG; Newland AC
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):169-71. PubMed ID: 8735810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet membrane glycoprotein abnormalities in myeloproliferative disease.
    Greaves M; Pickering C; Gugliotta L; Preston FE
    Br J Haematol; 1986 Apr; 62(4):780-2. PubMed ID: 3964566
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders.
    Jensen MK; de Nully Brown P; Lund BV; Nielsen OJ; Hasselbalch HC
    Br J Haematol; 2000 Jul; 110(1):116-24. PubMed ID: 10930987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble p-selectin should be measured in citrated plasma, not in serum.
    Caine GJ; Blann AD
    Br J Haematol; 2003 May; 121(3):530-2. PubMed ID: 12716382
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased platelet activation in subjects chronically exposed to cadmium: A pilot study.
    Nontarach A; Srihirun S; Chaturapanich G; Unchern S; Swaddiwudhipong W; Pattanapanyasat K; Chamchoi A; Vivithanaporn P; Visoottiviseth P; Sibmooh N
    Platelets; 2016; 27(2):136-42. PubMed ID: 26023812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year.
    Graf ME; Sookthai D; Johnson T; Schübel R; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
    Clin Biochem; 2017 Nov; 50(16-17):942-946. PubMed ID: 28571971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of platelet activation markers--selectin P and glycoprotein CD63 during hemodialysis].
    Walter-Croneck A; Belniak-Legieć E; Janicka L; Madro E; Krawczyk P
    Pol Arch Med Wewn; 1997 Nov; 98(11):424-30. PubMed ID: 9594560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble P-selectin is a marker of plaque destabilization in unstable angina.
    Draz N; Hamdy MS; Gomaa Y; Ramzy AA
    Egypt J Immunol; 2003; 10(1):83-7. PubMed ID: 15719626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation.
    Théorêt JF; Yacoub D; Hachem A; Gillis MA; Merhi Y
    Thromb Res; 2011 Sep; 128(3):243-50. PubMed ID: 21600632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Index for platelet activation].
    Nomura S
    Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1077-82. PubMed ID: 10892180
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies.
    Escolar G; White JG
    Thromb Haemost; 2000 Mar; 83(3):371-86. PubMed ID: 10744140
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
    Cherian P; Hankey GJ; Eikelboom JW; Thom J; Baker RI; McQuillan A; Staton J; Yi Q
    Stroke; 2003 Sep; 34(9):2132-7. PubMed ID: 12907813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy.
    Golukhova EZ; Grigoryan MV; Ryabinina MN; Bulaeva NI; Serebruany VL
    Cardiology; 2018; 139(2):132-136. PubMed ID: 29334682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of platelet activation to coronary angiographic severity and collateralization.
    Tan KT; Tayebjee MH; Macfadyen RJ; Lip GY
    Am J Cardiol; 2005 Jul; 96(2):208-10. PubMed ID: 16018843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble P-Selectin in Acute Exacerbations and Stable Bronchiectasis in Adults.
    Méndez R; Moscardó A; Latorre A; Feced L; González-Jiménez P; Piró A; Alcaraz-Serrano V; Scioscia G; Amaro R; Torres A; Menéndez R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1587-1591. PubMed ID: 31394907
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose.
    Carnevale R; Pastori D; Nocella C; Cammisotto V; Baratta F; Del Ben M; Angelico F; Sciarretta S; Bartimoccia S; Novo M; Targher G; Violi F
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):890-895. PubMed ID: 28743559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging value of P-selectin as a disease marker.
    Kappelmayer J; Nagy B; Miszti-Blasius K; Hevessy Z; Setiadi H
    Clin Chem Lab Med; 2004 May; 42(5):475-86. PubMed ID: 15202782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion molecules, platelet activation, and cardiovascular risk.
    Gurbel PA; Serebruany VL
    Am Heart J; 2002 Feb; 143(2):196-8. PubMed ID: 11835020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.